Chemoradiotherapy, Adjuvant
-
Subject Areas on Research
-
A Phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high-risk medulloblastoma (protocol POG 9631): A report from the Children's Oncology Group.
-
A multi-institutional cohort study of adjuvant therapy in stage I-II uterine carcinosarcoma.
-
A multi-institutional study of outcomes in stage I-III uterine carcinosarcoma.
-
A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.
-
ACR Appropriateness criteria® for nasopharyngeal carcinoma.
-
ACR appropriateness criteria® nasal cavity and paranasal sinus cancers.
-
Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance).
-
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.
-
Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies.
-
Adjuvant radiation therapy, androgen deprivation, and docetaxel for high-risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621.
-
Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy?
-
Adjuvant treatment and outcomes for patients with stage IIIA grade 1 endometrioid endometrial cancer.
-
Adjuvant treatment improves overall survival in women with high-intermediate risk early-stage endometrial cancer with lymphovascular space invasion.
-
Association Between Incomplete Neoadjuvant Radiotherapy and Survival for Patients With Locally Advanced Rectal Cancer.
-
Carcinoma of the ampulla of Vater: patterns of failure following resection and benefit of chemoradiotherapy.
-
Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.
-
Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer.
-
Clinicopathologic features and treatment in patients with early stage uterine clear cell carcinoma: A 16-year experience.
-
Colorectal cancer with potentially resectable hepatic metastases: optimizing treatment.
-
Dataset for the reporting of carcinoma of the esophagus in resection specimens: recommendations from the International Collaboration on Cancer Reporting.
-
Defining the Place of Adjuvant Chemotherapy and Radiation for High-Risk Endometrial Cancer From Recent Randomized Clinical Trials: Some Answers, More Questions.
-
Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?
-
Does radiologic response correlate to pathologic response in patients undergoing neoadjuvant therapy for borderline resectable pancreatic malignancy?
-
Effect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancer.
-
Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
-
FDG PET/CT in Patients With Head and Neck Squamous Cell Carcinoma After Primary Surgical Resection With or Without Chemoradiation Therapy.
-
Five year results of US intergroup/RTOG 9704 with postoperative CA 19-9 ≤90 U/mL and comparison to the CONKO-001 trial.
-
Glioma incidence and survival variations by county-level socioeconomic measures.
-
Hepatic Resection or Ablation for Isolated Breast Cancer Liver Metastasis: A Case-control Study With Comparison to Medically Treated Patients.
-
Impact of Positive Margins on Survival in Patients Undergoing Esophagogastrectomy for Esophageal Cancer.
-
Impact of patient selection and treatment strategies on outcomes after lobectomy for biopsy-proven stage IIIA pN2 non-small cell lung cancer.
-
Induction chemoradiation therapy prior to esophagectomy is associated with superior long-term survival for esophageal cancer.
-
Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer.
-
International practice survey on palliative lung radiotherapy: third international consensus workshop on palliative radiotherapy and symptom control.
-
Ipilimumab and Radiation in Patients with High-risk Resected or Regionally Advanced Melanoma.
-
Is follow-up CT imaging of the chest and abdomen necessary after preoperative neoadjuvant therapy in rectal cancer patients without evidence of metastatic disease at diagnosis?
-
Low- vs. High-Dose Neoadjuvant Radiation in Trimodality Treatment of Locally Advanced Esophageal Cancer.
-
Management of glioblastoma: State of the art and future directions.
-
Modeling pathologic response of esophageal cancer to chemoradiation therapy using spatial-temporal 18F-FDG PET features, clinical parameters, and demographics.
-
NCCN Guidelines Insights: Bone Cancer, Version 2.2017.
-
Nanostring-based multigene assay to predict recurrence for gastric cancer patients after surgery.
-
Neoadjuvant chemoradiation followed by transanal local excision for T2 rectal cancer confers equivalent survival benefit as traditional transabdominal resection.
-
No Difference in Survival between Neo-Adjuvant Chemotherapy and Neo-Adjuvant Chemoradiation Therapy in Gastric Cardia Cancer Patients: A Contemporary View from the National Cancer Database.
-
Overall health at diagnosis predicts the risk of complications within the first year after breast cancer diagnosis.
-
PET with Fluorodeoxyglucose F 18/Computed Tomography in the Clinical Management and Patient Outcomes of Esophageal Cancer.
-
Patterns of Failure After Surgery for Non-Small-cell Lung Cancer Invading the Chest Wall.
-
Patterns of recurrence after ablation of colorectal cancer liver metastases.
-
Patterns of recurrence after trimodality therapy for esophageal cancer.
-
Patterns of use and outcomes of sentinel lymph node mapping for patients with high-grade endometrial cancer.
-
Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma.
-
Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas.
-
Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses.
-
Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial.
-
Predictors of Long-Term Quality of Life for Survivors of Stage II/III Rectal Cancer in the Cancer Care Outcomes Research and Surveillance Consortium.
-
Preoperative radiation therapy in the surgical management of gastric and junctional adenocarcinoma: Should lymph node retrieval guidelines be altered?
-
Radiation and chemotherapy for high-risk lower grade gliomas: Choosing between temozolomide and PCV.
-
Randomized Phase II Trial Comparing Chemoradiotherapy with Chemotherapy for Completely Resected Unsuspected N2-Positive Non-Small Cell Lung Cancer.
-
Reply to L. Fornaro et al.
-
Resected irradiated rectal cancers: Are twelve lymph nodes really necessary in the era of neoadjuvant therapy?
-
Risk factors for surgical site infections after breast surgery: a systematic review and meta-analysis.
-
Role of Adjuvant Radiotherapy in Locally Advanced Colonic Carcinoma in the Modern Chemotherapy Era.
-
Role of Chemotherapy and Radiation Therapy in the Management of Gastric Adenocarcinoma.
-
Sentinel lymph node (SLN) isolated tumor cells (ITCs) in otherwise stage I/II endometrioid endometrial cancer: To treat or not to treat?
-
Spatial-temporal [¹⁸F]FDG-PET features for predicting pathologic response of esophageal cancer to neoadjuvant chemoradiation therapy.
-
Surgical resection after neoadjuvant chemoradiation for oesophageal adenocarcinoma: what is the optimal timing?
-
Survival Advantage With Adjuvant Chemotherapy for Locoregionally Advanced Rectal Cancer: A Veterans Health Administration Analysis.
-
Survival outcomes in sinonasal carcinoma with neuroendocrine differentiation: A NCDB analysis.
-
The ASTRO clinical practice guidelines in cervical cancer: Optimizing radiation therapy for improved outcomes.
-
The Role of Adjuvant Therapy in Patients With Margin-Positive (R1) Esophagectomy: A National Analysis.
-
The addition of chemotherapy to adjuvant radiation is associated with inferior survival outcomes in intermediate-risk HPV-negative HNSCC.
-
The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704.
-
The role of individualized treatment in patients with oesophageal cancer: mind the patient and not only the disease.
-
Treatment and Outcomes of Women With Large Locally Advanced Breast Cancer.
-
Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival.
-
VATS versus open surgery for lung cancer resection: moving toward a minimally invasive approach.
-
Weekly paclitaxel and carboplatin induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck.
-
Keywords of People